Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target MUC1 (clone O8KTH). We employs the Retrovirus (pUC-Cy2-IL-17-BamHI) vector components and the SynExpress system of the Exons Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Humanized
Target
MUC1
Clone
O8KTH
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
pUC
Effector Gene
IL-17
Insertion Sites
BamHI
Gene Modification
Knock-in
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.93
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.